Literature DB >> 14583449

p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.

Erica J Peterson1, Oliver Bögler, Shirley M Taylor.   

Abstract

Cytosine methylation patterns in genomic DNA are significantly altered in cancer, and de novo CpG island methylation has been implicated in tumor suppressor gene silencing. Here we demonstrate a mechanistic link between the p53 tumor suppressor gene and control of epigenetic regulation by genomic methylation. Deletion of p53in HCT116 human colon carcinoma cells and primary mouse astrocytes resulted in a 6-fold increase of DNA cytosine methyltransferase 1 (Dnmt1) mRNA and protein, suggesting relief of p53-mediated Dnmt1repression. A p53 consensus binding site in exon 1 of the human Dnmt1gene bound recombinant p53 in vitro and endogenous p53 in vivo in the absence of stimuli that activate p53, implying that p53 controls Dnmt1transcription through direct DNA binding. Interestingly, ionizing radiation or etoposide, both of which stabilize and activate p53, diminished p53 binding in chromatin immunoprecipitation assays, concomitant with a 5-fold increase in Dnmt1 levels. Our findings suggest that activation of p53 reduces binding and relieves transcriptional repression of the Dnmt1gene, whereas loss of p53, a frequent, early event in tumorigenesis, may significantly contribute to aberrant genomic methylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583449

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model.

Authors:  Alexandre Mezentsev; Sally A Amundson
Journal:  Radiat Res       Date:  2011-04-12       Impact factor: 2.841

2.  MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.

Authors:  Masoumeh Azizi; Ladan Teimoori-Toolabi; Mohsen Karimi Arzanani; Kayhan Azadmanesh; Pezhman Fard-Esfahani; Sirous Zeinali
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

3.  Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters.

Authors:  Pierre-Olivier Estève; Hang Gyeong Chin; Sriharsa Pradhan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

4.  Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer.

Authors:  Young-Mi Kwon; Jung Ho Park; Hojoong Kim; Young Mog Shim; Jhingook Kim; Joungho Han; Joobae Park; Duk-Hwan Kim
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-20       Impact factor: 4.553

5.  Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells.

Authors:  Karolina Skowronski; Sonam Dubey; David Rodenhiser; Brenda Coomber
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

Review 6.  An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function.

Authors:  Swayamsiddha Kar; Moonmoon Deb; Dipta Sengupta; Arunima Shilpi; Sabnam Parbin; Jérôme Torrisani; Sriharsa Pradhan; Samir Patra
Journal:  Epigenetics       Date:  2012-08-16       Impact factor: 4.528

7.  DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria.

Authors:  Lisa S Shock; Prashant V Thakkar; Erica J Peterson; Richard G Moran; Shirley M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

8.  Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies.

Authors:  Rituparna Mukhopadhyay; Sylvain V Costes; Alexey V Bazarov; William C Hines; Mary Helen Barcellos-Hoff; Paul Yaswen
Journal:  Breast Cancer Res       Date:  2010-02-10       Impact factor: 6.466

9.  XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center.

Authors:  Franco M Muggia; Godefridus J Peters; Joseph R Landolph
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

10.  Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.

Authors:  Matteo Rossi; Oleg N Demidov; Carl W Anderson; Ettore Appella; Sharlyn J Mazur
Journal:  Nucleic Acids Res       Date:  2008-11-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.